IHC was pivotal: positive HMB-45 and Melan-A staining confirmed AML, reflecting its mesenchymal origin, while negative CK7 and PAX8 excluded RCC, which typically expresses these epithelial markers in clear cell and papillary subtypes3. This evidence concerns the gene PMEL and acute myeloid leukemia.